Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · third_quarter · Q3
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · 1A
Source: Senate LDA
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Strengthening Public Health Emergency Response Act of 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Provider Payment Sunshine Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
Protecting Access to Medicare Act of 2014
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax
21st Century Global Health Technology Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.2407, 21st Century Global Health Technology Act of 2014 NIH funding PEPFAR funding
21st Century Global Health Technology Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.2407, 21st Century Global Health Technology Act of 2014 NIH funding PEPFAR funding
Medicare Safe Needle Disposal Coverage Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Medicare Safe Needle Disposal Coverage Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Government Neutrality in Contracting Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act, related to device tax Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 Corporate tax issues
Protect Medical Innovation Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
Pharmaceutical Quality, Security, and Accountability Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests
Pharmaceutical Quality, Security, and Accountability Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests Healthcare policy and medical technology issues Issues relating to injection safety for patients and healthcare workers
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH funding H.J. Res. 117, Continuing Appropriations Resolution, 2013, regarding FDA funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH Funding PL 112-025, Budget Control Act of 2011, related to NIH Funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, NIH, CDC, Global Health Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, NIH, CDC, Global Health Funding PL 112-025, Budget Control Act of 2011, issues related to NIH funding
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to FDA regulation of generic drugs
MODDERN Cures Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3497, MODDERN Cures Act of 2011
MODDERN Cures Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3497, Modern Cures Act of 2011
Health Care Cost Reduction Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
Health Care Cost Reduction Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 Corporate tax issues
Food and Drug Administration Reform Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
Manufacturing American Innovation Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
Health Care Innovation and Marketplace Technologies Act of 2012
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.6626, Health Care Innovation and Marketplace Technologies Act of 2012 Sunshine Act
Regenerative Medicine Promotion Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.1862, Regenerative Medicine Promotion Act of 2011
Generating Antibiotic Incentives Now Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 H.R.2182, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections S.1734, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to cervical cancer screening Issues related to FDA regulation of generic drugs Issues related to pandemic influenza preparedness
Generating Antibiotic Incentives Now Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues H.R.2182, Generating Antibiotic Incentives Now Act of 2011 Issues related to safe injection practices Issues related to pandemic influenza preparedness Introducing the company based on geographic or health product-based relevance
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 H.R.2182, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections S.1734, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to cervical cancer screening Issues related to FDA regulation of generic drugs Issues related to pandemic influenza preparedness
MODDERN Cures Act of 2011
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 3497, Modern Cures Act of 2011
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · second_quarter · Q2
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety
NIH Funding Global Health Funding
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · Q1
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · 4A
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · 3A
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · 2A
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · Q4
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · Q3
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · Q2
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · first_quarter · Q1
NIH Funding Global Health Funding Appropriations Budget
Issues related to medical device tax repeal Issues related to international tax
Issues related to diagnostic regulation Bio-specimen regulatory issue Issues related to drug shortages Issues related to pandemic preparedness Issues related to Health IT
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · fourth_quarter · Q4
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · third_quarter · Q3
Issues related to Sharps disposal reimbursement Diagnostics reimbursement Issues related to UDI on medical claim forms
NIH Funding
Issues related to diagnostic regulation Issues related to drug shortages Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · 2A
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to Trade Promotion Authority (TPA) Issues related to Trans-Pacific Partnership (TPP)
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · 1A
NIH Funding BARDA Funding
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · Q2
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to Trade Promotion Authority (TPA) Issues related to Trans-Pacific Partnership (TPP)
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · Q1
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
NIH Funding BARDA Funding
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · 4A
NIH Funding
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · 3A
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · 2A
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · 1A
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
H.R. 436, Protect Medical Innovation Act, related to device tax
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · Q4
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · Q3
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · Q2
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · Q1
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · fourth_quarter · Q4
Physician Fee Schedule draft rule Reimbursement for diagnostic tests
NIH Funding
H.R. 436, Protect Medical Innovation Act, related to device tax Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · third_quarter · Q3
Reimbursement for diagnostic tests
NIH Funding FDA Funding PEPFAR Funding
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · second_quarter · Q2
Diagnostic reimbursement
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests Healthcare policy and medical technology issues Issues relating to injection safety for patients and healthcare workers
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · first_quarter · Q1
Diagnostic reimbursement
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
NIH Funding FDA Funding PEPFAR
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · fourth_quarter · Q4
H.R.6626, Health Care Innovation and Marketplace Technologies Act of 2012 Sunshine Act
H.R. 436, Protect Medical Innovation Act of 2011 Corporate tax issues
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH funding H.J. Res. 117, Continuing Appropriations Resolution, 2013, regarding FDA funding
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · third_quarter · Q3
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH Funding PL 112-025, Budget Control Act of 2011, related to NIH Funding
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
H.R. 3497, MODDERN Cures Act of 2011
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · second_quarter · Q2
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, NIH, CDC, Global Health Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, NIH, CDC, Global Health Funding PL 112-025, Budget Control Act of 2011, issues related to NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · first_quarter · Q1
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to FDA regulation of generic drugs
Issues related to NIH funding Issues related to global health funding
Corporate tax issues Issues related to Medical Device Tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · fourth_quarter · Q4
H.R. 3497, Modern Cures Act of 2011
Issues related to NIH funding Issues related to global health funding
Corporate tax issues Issues related to Medical Device Tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · third_quarter · Q3
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Issues related to cervical cancer screening Issues related to safe injection practices Issues related to pandemic influenza preparedness
Issues related to NIH funding
Issues related to reimbursement for diagnostics Issues related to healthcare reform implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · second_quarter · Q2
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues H.R.2182, Generating Antibiotic Incentives Now Act of 2011 Issues related to safe injection practices Issues related to pandemic influenza preparedness Introducing the company based on geographic or health product-based relevance
H.R.1862, Regenerative Medicine Promotion Act of 2011
Issues related to reimbursement for diagnostics Issues related to healthcare reform implementation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · first_quarter · Q1
Issues related to reimbursement for diagnostics Issues related to Medicare value-based purchasing
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Healthcare reform implementation Safe injection practices Introducing the company based on geographic or health product-based relevance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2010 · fourth_quarter · Q4
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Introducing the company based on geographic or health product-based relevance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diagnostics reimbursement Issues related to UDI on medical claim forms Issues related to patient safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.2407, 21st Century Global Health Technology Act of 2014 NIH funding PEPFAR funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.2407, 21st Century Global Health Technology Act of 2014 NIH funding PEPFAR funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 436, Protect Medical Innovation Act, related to device tax
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.523, Protect Medical Innovation Act of 2013 Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIH Funding FDA Funding PEPFAR
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Healthcare policy and medical technology issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3497, Modern Cures Act of 2011
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 H.R.2182, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections S.1734, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to cervical cancer screening Issues related to FDA regulation of generic drugs Issues related to pandemic influenza preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to PEPFAR funding Issues related to NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE